Sun Pharmaceutical Industries Ltd. benchmarking: Perfomance to industry peers

Financial

	Sun Pharma Inds.	Cipla	Torrent Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	661.0 .	285.0 .	172.0 .
Number of ANDA's Approved By USFDA	542.0 .	225.0 .	132.0 .
Domestic Sales Growth - YoY	12.0 %	6.8 %	12.3 %
US DMF Filings	529.0 .	2472.0 .	n/a
US DMF Approval	401.0 .	n/a	n/a
R&D as a % of Total Sales	6.5 %	7.1 %	5.0 %
Financials
5 yr Average ROE	11.67 %	13.9 %	20.79 %
5yr average Equity Multiplier	1.33	1.25	2.16
5yr Average Asset Turnover Ratio	0.57	0.78	0.69
5yr Avg Net Profit Margin	15.4 %	14.31 %	13.95 %
Price to Book	5.67	3.71	16.18
P/E	39.49	22.44	61.34
5yr Avg Cash Conversion Cycle	-46.88 Days	-4.31 Days	-186.79 Days
Inventory Days	65.22 Days	57.83 Days	54.98 Days
Days Receivable	84.33 Days	50.64 Days	40.18 Days
Days Payable	175.41 Days	105.99 Days	298.32 Days
5yr Average Interest Coverage Ratio	44.12	53.73	7.38
5yr Avg ROCE	18.0 %	19.36 %	25.78 %
5yr Avg Operating Profit Margin	26.44 %	23.02 %	30.49 %
5 yr average Debt to Equity	0.06	0.03	0.66
5yr CAGR Net Profit	30.35 %	17.0 %	8.83 %
5yr Average Return on Assets	8.92 %	11.19 %	9.73 %
Shareholdings
Promoter Holding	54.48 %	29.21 %	68.31 %
Share Pledged by Promoters	0.97 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-4.4 %	-2.94 %
Change in Mutual Fund Holding (3 Yrs)	0.19 %	6.45 %	-1.6 %

Business

	Sun Pharma Inds.	Cipla	Torrent Pharma
Product Wise Break-Up	Product Wise Break-Up India Branded Generics 33.0 US Formulations 31.0 Emerging Market 18.0 Western Europe & Other Markets 13.0 Active Pharmaceutical Ingredient (API) 5.0 New ventures 0 Pharmaceuticals 0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0	Product Wise Break-Up US Formulations 0 Western Europe & Other Markets 0 Emerging Market 0 New ventures 6.32 India Branded Generics 0 Pharmaceutical 93.68 Domestic formulations 0 Active Pharmaceutical Ingredient (API) 0 Germany/Europe 0 Contract Manf. 0 Brazil/Latam 0	Product Wise Break-Up US Formulations 20.71 Western Europe & Other Markets 0 Emerging Market 0 New ventures 0 India Branded Generics 0 Pharmaceuticals 0 Domestic Formulations 42.15 Active Pharmaceutical Ingredient (API) 0 Germany 13.15 Contract Manufacturing 6.15 Brazil 8.98 Others 8.86
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 20.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 8.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Anti-infectives 0 Cardiac 0 Gastro Intestinal 0 Antivirals 0 Derma 0 Neuro /CNS 0 Gynaec. 0 Vitamins 0 Antineoplast 0 Opthal/Otologicals 0 Oncology 0 Anti Diabetic 0 Others 4.0	Therapeutic Area Wise Break-Up - Domestic Oncology 0 Vitamins / Minerals / Nutrients 0 Ophthalmology 0 Antivirals 0 Ophthalmology 2.6 Gynecology 0 Anti - Diabetes 5.5 Derma 3.5 Central Nervous System (CNS) 0 Gastro Intestinal 5.5 Respiratory Systems 0 Gynaec. 0 Vitamins 0 Urology 5.1 Anti - Diabetes 0 Central Nervous System (CNS) 4.5 Cardiac Science 11.8 Anti-Infective 13.8 Anti-Infective 0 Dermatology 0 Cardiac Science 0 Antineoplast 0 Pain Management 0 Others 47.7	-
Location Wise Break-Up	Location Wise Break-Up India 33.39 USA 32.68 Emerging Market 19.13 Rest of the World 14.8 SAGA 0 Europe 0 Global API 0 North America 0 Germany 0 Brazil 0	Location Wise Break-Up Rest of the World 0 Brazil 0 USA 0 SAGA 13.0 Europe 12.0 Germany 0 Emerging Market 0 North America 28.0 India 44.0 Global API 1.0 Others 2.0	Location Wise Break-Up Rest of the World 0 Brazil 6.86 USA 9.69 SAGA 0 Europe 0 Germany 9.69 Emerging Market 0 North America 0 India 56.99 Global API 0 Others 16.77

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

Financial

Business

SIGN UP FOR FREE